Recent Developments and Current Challenges of Heparin-Grafted Hemodialysis Membranes

Recent Developments and Current Challenges of Heparin-Grafted Hemodialysis Membranes

Hemodialysis (HD) is a life-sustaining extracorporeal blood purifying treatment for end-stage renal disease (ESRD) patients. However, this membrane-based therapy is associated with acute side effects, life-threatening chronic conditions, and unacceptably high morbidity and mortality rates. Numerous...

Full description

Bibliographic Details
Main Authors:	Amira Abdelrasoul, Denis Kalugin, Ahmed Shoker
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Journal of Composites Science
Subjects:	hemodialysis membrane heparin hemocompatibility anticoagulant immobilization
Online Access:	https://www.mdpi.com/2504-477X/6/9/244

Similar Items

Heparin-Immobilized Polyethersulfone for Hemocompatibility Enhancement of Dialysis Membrane: In Situ Synchrotron Imaging, Experimental, and Ex Vivo Studies
by: Denis Kalugin, et al.
Published: (2023-08-01)

Enhancing the hemocompatibility of polyethersulfone (PES) hemodialysis membranes using synthesized pseudo zwittronic polymers with various orientations
by: Anubhab Patra, et al.
Published: (2023-10-01)

Impact of Membrane Modification and Surface Immobilization Techniques on the Hemocompatibility of Hemodialysis Membranes: A Critical Review
by: Simin Nazari, et al.
Published: (2022-10-01)

Comparing the Effects of Three Heparinization Methods of Hemodialysis Set on the Amount of Clot Formation during Hemodialysis
by: M Kazemi, et al.
Published: (2005-07-01)

Characterization of Butanediol-Alginate Ester as Candidate of Hemodialysis Membrane
by: Choirul Amri, et al.
Published: (2015-07-01)

Effect of β-cyclodextrin on the hemocompatibility of heparin-modified PMP hollow fibrous membrane for Extracorporeal Membrane Oxygenation (ECMO)
by: Xingrui Zhong, et al.
Published: (2023-06-01)

Surface Coating of Polyurethane Films with Gelatin, Aspirin and Heparin to Increase the Hemocompatibility of Artificial Vascular Grafts
by: Simzar Hosseinzadeh, et al.
Published: (2023-01-01)

Surface zwitterionization of hemodialysismembranesfor hemocompatibility enhancement and protein-mediated anti-adhesion: A critical review
by: Simin Nazari, et al.
Published: (2022-06-01)

Hemocompatibility enhancement of polyethersulfone membranes: Strategies and challenges
by: Xin Song, et al.
Published: (2021-01-01)

In situ synchrotron quantitative analysis of competitive adsorption tendency of human serum protein to different clinical hemodialysis membranes and assessment of potential impacts
by: Amira Abdelrasoul, et al.
Published: (2023-11-01)

Influence of hydration shell of hemodialysis clinical membranes on surrogate biomarkers activation in uremic serum of dialysis patients
by: Amira Abdelrasoul, et al.
Published: (2022-12-01)

Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
by: Christophe Leroy, et al.
Published: (2021-01-01)

In-Vitro Endothelialization Assessment of Heparinized Bovine Pericardial Scaffold for Cardiovascular Application
by: My Thi Ngoc Nguyen, et al.
Published: (2022-05-01)

Influence of clinical hemodialysis membrane morphology and chemistry on protein adsorption and inflammatory biomarkers released: In-situ synchrotron imaging, clinical and computational studies
by: Zhu Sishi, et al.
Published: (2023-06-01)

Structure, function, and adsorption of highly abundant blood proteins and its critical influence on hemodialysis patients: A critical review
by: Heloisa Westphalen, et al.
Published: (2021-12-01)

Novel insights in hemodialysis: Most recent theories on membrane hemocompatibility improvement
by: Arash Mollahosseini, et al.
Published: (2022-06-01)

Influence of Dipole Orientation of Zwitterionic Materials on Hemodialysis Membrane Interactions with Human Serum Proteins
by: Simin Nazari, et al.
Published: (2023-11-01)

Comparison of Three Heparinization Methods of Hemodialysis Set on Coagulation Condition and Dialysis Efficacy in Patient Undergoing Hemodialysis
by: H Dehghani, et al.
Published: (2014-06-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Intracranial hemorrhage in methanol toxicity: Challenging the probable heparin effect during hemodialysis
by: Hossein Hassanian-Moghaddam, et al.
Published: (2017-01-01)

Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis
by: Ghanshyam Palamaner Subash Shantha, et al.
Published: (2015-03-01)

Tissue plasminogen activator versus heparin for locking dialysis catheters: A systematic review
by: Belal M Firwana, et al.
Published: (2011-10-01)

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis
by: Kušić Jovana, et al.
Published: (2016-01-01)

EFFECT OF HEPARIN ON THE PATENCY OF ARTERIOVENOUS FISTULA
by: H Ravari, et al.
Published: (2008-11-01)

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01)

Strategies to Overcome Heparins’ Low Oral Bioavailability
by: Ana Rita Neves, et al.
Published: (2016-06-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Investigation on Human Serum Protein Depositions Inside Polyvinylidene Fluoride-Based Dialysis Membrane Layers Using Synchrotron Radiation Micro-Computed Tomography (SR-μCT)
by: Amira Abdelrasoul, et al.
Published: (2023-01-01)

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-relared inhibitors /
by: Brankamp, R. G.

Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation
by: Giovana Seno Di Marco, et al.
Published: (2024-03-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017-10-01)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020-09-01)

Grafting of Heparin on Blend Membrane of Citric Acid Crosslinked Chitosan/Polyethylene Glycol-Poly Vinyl Alcohol (PVA-PEG)
by: Retno Ariadi Lusiana, et al.
Published: (2019-01-01)

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Heparin induced thrombocytopenia in pregnancy: A therapeutic challenge case report and literature review
by: Seyyed Mojtaba Nekooghadam, et al.
Published: (2023-08-01)

Occurrence and structural characterization of heparin from molluscs
by: N Volpi
Published: (2005-02-01)